Related Experiment Video
Updated: May 24, 2026
08:27
Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018
A turning point for Alzheimer's disease?
1Department of Psychology, University of Texas at Austin, Austin, TX, USA. jcdelatorre@comcast.net
Biofactors (Oxford, England)
|March 17, 2012
Summary
Preventing Alzheimer's disease (AD) requires addressing vascular risk factors early through identification, detection, and intervention. A proactive lifestyle complements these strategies to combat this multifactorial disorder.
Area of Science:
- Neuroscience
- Gerontology
- Preventive Medicine
Background:
- Despite extensive research, clinical progress in understanding and preventing sporadic Alzheimer's disease (AD) remains limited.
- Alzheimer's disease is increasingly viewed as a multifactorial disorder linked to aging and vascular issues.
Purpose of the Study:
- To review strategic approaches for lowering Alzheimer's disease prevalence.
- To highlight the role of vascular risk factors and lifestyle in AD prevention.
Main Methods:
- Review of existing research on Alzheimer's disease pathogenesis and prevention.
- Focus on a four-pillar prevention strategy targeting vascular risk factors.
- Emphasis on evidence-based medical decisions and patient follow-up.
Main Results:
- A four-pillar strategy (early identification, detection, intervention, and follow-up of vascular risk factors) is proposed.
- Chronic brain hypoperfusion (CBH) due to vascular risk factors is implicated in AD.
- A cascade involving oxidative stress, neurodegeneration, and biofactors (micronutrients, metals, lipids) is associated with CBH.
Conclusions:
- Early and comprehensive management of vascular risk factors is crucial for Alzheimer's disease prevention.
- Lifestyle modifications, including diet and physical/mental activity, are vital components of AD intervention.
- Modulating key biofactors may offer a pathway to prevent or manage incipient Alzheimer's disease.
Related Concept Videos
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.